The short version
Defy Medical is one of the longer-running clinics in the hormone-optimization space, with a wide protocol library spanning HRT, TRT, peptides, and ancillaries. The intake is comprehensive, the labs are extensive, and the relationship is shaped like a real clinic — multiple providers, follow-up, a wide formulary. Members usually come in expecting a full workup.
Boswell is a peptide-therapy platform. The compound menu is intentionally focused: BPC-157, CJC-1295 + Ipamorelin, sermorelin, NAD+, PT-141, TB-500, AOD-9604, GHK-Cu, MOTS-C, glutathione. The unit of value is the protocol, prescribed by a U.S.-licensed physician and compounded by a 503A pharmacy.
| Topic | Defy Medical | Boswell |
|---|---|---|
| Primary product | Hormone-led clinical care across HRT, TRT, peptides, and ancillaries | Peptide therapy via licensed providers + 503A compounding |
| Breadth | Wide protocol library across many compound categories | Focused peptide menu with provider oversight |
| Starting point | Comprehensive intake + extensive lab panel, then a tailored plan | Goals review, provider intake, then a prescribed protocol |
| Peptide approach | Available alongside hormone work | Peptide-first, full menu (BPC-157, TB-500, CJC-1295 + Ipa, NAD+, PT-141, GHK-Cu, MOTS-C, AOD-9604, Sermorelin, Glutathione) |
| Pricing model | Consultation + lab + medication, often layered | Per-protocol pricing, prescription-required |
| Best fit | You want a comprehensive hormone-and-peptide clinic relationship | You want a specific peptide protocol with provider oversight |
Different jobs to be done
Defy Medical is structured around I want a longitudinal clinic relationship covering hormones, peptides, and ancillaries. The breadth is the value — wide intake, wide labs, wide formulary, ongoing care. It's optimized for the patient who treats this as their primary preventive-medicine relationship.
Boswell is structured around can I get this peptide protocol prescribed cleanly and compounded properly? The breadth is narrower on purpose, the protocol depth is greater, and the pricing reflects what you're actually paying for: the medication and the prescriber, not a comprehensive clinic wrapper.
A wide clinic and a focused platform are both legitimate answers — to different questions.
When Defy Medical makes sense
Defy Medical earns its place when you want a real, longitudinal clinic relationship — full hormone management, a wide formulary, and providers who'll see you across many years. If you've thought through what hormone optimization means for you and want a single experienced clinic to coordinate everything, the comprehensive model is built for that.
It's also a reasonable choice if you anticipate needing a wide variety of compounds and would rather pay for the relationship than for individual protocols. The trade-off is the layered cost structure and a less peptide-forward experience.
When Boswell makes sense
Boswell earns its place when you've already identified the peptide. You want BPC-157 for a tendon. You're stacking CJC-1295 + Ipamorelin for sleep and recovery. You want PT-141 for sexual health, NAD+ for cellular energy, or GHK-Cu for skin support.
The value is direct access to the protocol — under a U.S.-licensed prescriber, compounded fresh by a 503A pharmacy, with refill oversight and the labeling that gray-market sources don't provide. Pricing is per-protocol, not bundled into a comprehensive clinic relationship. If you want a wide hormone clinic, Defy is built for that. If you want a peptide protocol prescribed cleanly, this is.
Questions worth asking before either
- Do I want a comprehensive clinic relationship, or do I want one prescribed protocol?
- How much of what I'd be paying is for medication vs. for the clinic wrapper?
- Is the prescriber a U.S.-licensed physician, and is the pharmacy a 503A compounding pharmacy?
- What does refill oversight look like — who follows up, and when?
- Will I genuinely use the breadth of a comprehensive clinic, or am I paying for it without using it?
Sources